R
Riccardo M. Inciardi
Researcher at University of Brescia
Publications - 98
Citations - 2981
Riccardo M. Inciardi is an academic researcher from University of Brescia. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 11, co-authored 44 publications receiving 1795 citations. Previous affiliations of Riccardo M. Inciardi include University of Palermo & Harvard University.
Papers
More filters
Journal ArticleDOI
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).
Riccardo M. Inciardi,Laura Lupi,Gregorio Zaccone,Leonardo Italia,Michela Raffo,Daniela Tomasoni,Dario Cani,Manuel Cerini,Davide Farina,Emanuele Gavazzi,Roberto Maroldi,Marianna Adamo,Enrico Ammirati,Gianfranco Sinagra,Carlo Lombardi,Marco Metra +15 more
TL;DR: This case report describes an otherwise healthy 53-year-old woman who tested positive for CO VID-19 and was admitted to the cardiac care unit in March 2020 for acute myopericarditis with systolic dysfunction, confirmed on cardiac magnetic resonance imaging, the week after onset of fever and dry cough due to COVID-19.
Journal ArticleDOI
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy.
Riccardo M. Inciardi,Marianna Adamo,Laura Lupi,Dario Cani,Mattia Di Pasquale,Daniela Tomasoni,Leonardo Italia,Gregorio Zaccone,Chiara Tedino,Davide Fabbricatore,Antonio Curnis,Pompilio Faggiano,Elio Gorga,Carlo Lombardi,G Milesi,Enrico Vizzardi,M. Volpini,Savina Nodari,Claudia Specchia,Roberto Maroldi,Michela Bezzi,Marco Metra +21 more
TL;DR: Hospitalized patients with concomitant cardiac disease and COVID-19 have an extremely poor prognosis compared with subjects without a history of cardiac disease, with higher mortality, thrombo-embolic events, and septic shock rates.
Journal ArticleDOI
COVID 19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease
Daniela Tomasoni,Leonardo Italia,Marianna Adamo,Riccardo M. Inciardi,Carlo Lombardi,Scott D. Solomon,Marco Metra +6 more
TL;DR: Recent data show the lack of untoward effects of ACE inhibitors or angiotensin receptor blockers for COVID‐19 infection and severity, and Prospective trials are needed to ascertain whether these drugs may have protective effects.
Journal ArticleDOI
Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study.
Carlo Lombardi,Valentina Carubelli,Annamaria Iorio,Riccardo M. Inciardi,Antonio Bellasi,Claudia Canale,Rita Camporotondo,Francesco Catagnano,Laura Adelaide Dalla Vecchia,Stefano Giovinazzo,Gloria Maccagni,Massimo Mapelli,Davide Margonato,Luca Monzo,Vincenzo Nuzzi,Chiara Oriecuia,Giulia Peveri,Giulia Peveri,Andrea Pozzi,Giovanni Provenzale,Filippo M. Sarullo,Daniela Tomasoni,Pietro Ameri,Massimiliano Gnecchi,Sergio Leonardi,Marco Merlo,Piergiuseppe Agostoni,Stefano Carugo,Gian Battista Danzi,Marco Guazzi,Maria Teresa La Rovere,Andrea Mortara,Massimo F Piepoli,Massimo F Piepoli,Italo Porto,Gianfranco Sinagra,Maurizio Volterrani,Claudia Specchia,Marco Metra,Michele Senni +39 more
TL;DR: Elevated troponin was an independent variable associated with in-hospital mortality and a greater risk of cardiovascular and noncardiovascular complications during a hospitalization for COVID-19, and this was independent from concomitant cardiac disease.
Journal ArticleDOI
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study.
Daniela Tomasoni,Riccardo M. Inciardi,Carlo Lombardi,Chiara Tedino,Piergiuseppe Agostoni,Pietro Ameri,Lucia Barbieri,Antonio Bellasi,Rita Camporotondo,Claudia Canale,Valentina Carubelli,Stefano Carugo,Francesco Catagnano,Laura Adelaide Dalla Vecchia,Gian Battista Danzi,Mattia Di Pasquale,Margherita Gaudenzi,Stefano Giovinazzo,Massimiliano Gnecchi,Annamaria Iorio,Maria Teresa La Rovere,Sergio Leonardi,Gloria Maccagni,Massimo Mapelli,Davide Margonato,Marco Merlo,Luca Monzo,Andrea Mortara,Vincenzo Nuzzi,Massimo F Piepoli,Massimo F Piepoli,Italo Porto,Andrea Pozzi,Filippo M. Sarullo,Gianfranco Sinagra,Maurizio Volterrani,Gregorio Zaccone,Marco Guazzi,Michele Senni,Marco Metra +39 more
TL;DR: To assess the prognostic value of a history of heart failure (HF) in patients with coronavirus disease 2019 (COVID‐19), a large number of patients were diagnosed with atypical heart failure in the previous 12 months.